Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Diabetes Health Mobile App
DHTV
Popular
Top Rated

Related Products Videos on Diabetes Health TV

Easy to Use Insulin Delivery Patch

Anna Tucker

Easy to Use Insulin Delivery Patch

One of Our Advisory Board Members Wields a Mighty Pen

Jane Seley, GNP, MPH, MSN, CDE

One of Our Advisory Board Members Wields a Mighty Pen

Paradigm Real Time Pump & Sensor

Bruce W. Bode M.D.

Paradigm Real Time Pump & Sensor

View all Videos…
Eli Lilly Archives
Browse the Eli Lilly Archives
Subscribe to the Products RSS Feed

Eli Lilly

Products RSS Feed RSS
Updated 11 weeks ago
 
Lilly Begins Sales of Jentadueto, a Combo Drug for Type 2s
news
Lilly Begins Sales of Jentadueto, a Combo Drug for Type 2s

Comments 0 comments - Mar 10, 2012 - * * * * *

Helping African Americans F.A.C.E. Their Risk for Diabetes
blog
Helping African Americans F.A.C.E. Their Risk for Diabetes

Diabetes Health publisher Nadia Al-Samarrie recently spoke with television and movie actor Anthony Anderson, who has taken a lead role with Eli Lilly & Company's F.A.C.E. campaign, a diabetes outreach to African Americans. A veteran of more than 20 films, Anthony, age 41, currently plays Detective Kevin Bernard on NBC's Emmy Award-winning drama, "Law & Order."

Comments 1 comment - Nov 27, 2011 - * * * * *

Tradjenta, a Drug for Type 2s, Now on U.S. Market
news
Tradjenta, a Drug for Type 2s, Now on U.S. Market

Boehringer Ingelheim and Eli Lilly have begun sales of Tradjenta, a drug for type 2 diabetes, in U.S. pharmacies. The drug (generic name linagliptin) comes in tablet form and is intended to compete with Amylin Pharmaceuticals' Byetta, which is injected, and Merck's Januvia, which also competes with Byetta. Both are well-established in the U.S. market.

Comments 2 comments - Jul 27, 2011 - * * * * *

Sanofi Says Late-Stage Trial of Type 2 Drug a Success
news
Sanofi Says Late-Stage Trial of Type 2 Drug a Success

French drug maker Sanofi-aventis says that results from a Phase III trial of its experimental type 2 diabetes drug lixisenatide show that the drug successfully lowered patients' blood glucose levels and body weight, but did not increase the risk of hypoglycemia.

Comments 0 comments - May 23, 2011 - * * * * *

 
©1991-2012 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.